FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313398075> ?p ?o ?g. }

• W4313398075 endingPage "294" @default.
• W4313398075 startingPage "279" @default.
• W4313398075 abstract "Immunotherapy, along with chemotherapy, targeted delivery, radiation and surgery has become one of the most common cancer treatments. The aim of cancer immunology is to use the bodys immune system to combat tumors and develop a robust antitumor immune response. In the last few years, immune checkpoint inhibitors and chimeric antigen receptor-modified T cells have made substantial advancements in cancer immunotherapy. By boosting cell type-specific delivery and immunological responses, nanocarriers like liposomes have the ability to enhance greater immune responses. The efficacy of anti-tumor therapeutics is being significantly improved as liposomes can assist in resolving a number of issues that can arise from a variety of cancer immunotherapies. Since, liposomes can be loaded with both hydrophilic and hydrophobic drugs and protect the immunotherapeutic agents loaded inside the core, they offer significant advantages over other nano delivery systems. The use of liposomes for accurate and timely delivery of immunotherapies to particular targeted neoplasms, with little or no injury to healthy cells, maximizes immunotherapy efficacy. Liposomes are also suitable vehicles for delivering medications simultaneously with other therapies such as chemotherapy, radiation, and phototherapy. Liposomal nanoparticles will be introduced and used as an objective immunotherapy delivery system for great precision, making them a viable cancer treatment approach.With an emphasis on dendritic cells, T cells, tumor and natural killer cells, and macrophages; outline of many forms of immune-therapies in oncology and cutting-edge advances in liposomal nanovesicles for cancer immunotherapy are covered in this review." @default.
• W4313398075 created "2023-01-06" @default.
• W4313398075 creator A5014615503 @default.
• W4313398075 creator A5016101966 @default.
• W4313398075 creator A5019967714 @default.
• W4313398075 creator A5032120336 @default.
• W4313398075 creator A5035109980 @default.
• W4313398075 creator A5040757168 @default.
• W4313398075 creator A5064719453 @default.
• W4313398075 creator A5091048061 @default.
• W4313398075 date "2023-02-01" @default.
• W4313398075 modified "2023-10-01" @default.
• W4313398075 title "Recent advances in the liposomal nanovesicles based immunotherapy in the treatment of cancer: A review" @default.
• W4313398075 cites W1533498236 @default.
• W4313398075 cites W1605630196 @default.
• W4313398075 cites W1661544713 @default.
• W4313398075 cites W1933597528 @default.
• W4313398075 cites W1973525513 @default.
• W4313398075 cites W1989230986 @default.
• W4313398075 cites W1994993231 @default.
• W4313398075 cites W2002250199 @default.
• W4313398075 cites W2003690177 @default.
• W4313398075 cites W2008210213 @default.
• W4313398075 cites W2014657278 @default.
• W4313398075 cites W2016829755 @default.
• W4313398075 cites W2016849804 @default.
• W4313398075 cites W2019613864 @default.
• W4313398075 cites W2020555045 @default.
• W4313398075 cites W2022996006 @default.
• W4313398075 cites W2023643738 @default.
• W4313398075 cites W2032110128 @default.
• W4313398075 cites W2036320072 @default.
• W4313398075 cites W2036422868 @default.
• W4313398075 cites W2044069347 @default.
• W4313398075 cites W2044568975 @default.
• W4313398075 cites W2044835625 @default.
• W4313398075 cites W2050216284 @default.
• W4313398075 cites W2050417053 @default.
• W4313398075 cites W2051053191 @default.
• W4313398075 cites W2054985451 @default.
• W4313398075 cites W2055954661 @default.
• W4313398075 cites W2056893124 @default.
• W4313398075 cites W2076226743 @default.
• W4313398075 cites W2080248628 @default.
• W4313398075 cites W2097995306 @default.
• W4313398075 cites W2100587627 @default.
• W4313398075 cites W2101490383 @default.
• W4313398075 cites W2103959341 @default.
• W4313398075 cites W2119703555 @default.
• W4313398075 cites W2119871165 @default.
• W4313398075 cites W2120158787 @default.
• W4313398075 cites W2131950300 @default.
• W4313398075 cites W2137000696 @default.
• W4313398075 cites W2138378181 @default.
• W4313398075 cites W2140143664 @default.
• W4313398075 cites W2142153200 @default.
• W4313398075 cites W2142887729 @default.
• W4313398075 cites W2143145234 @default.
• W4313398075 cites W2146729875 @default.
• W4313398075 cites W2161946327 @default.
• W4313398075 cites W2177405394 @default.
• W4313398075 cites W2220882815 @default.
• W4313398075 cites W2257916459 @default.
• W4313398075 cites W2269881068 @default.
• W4313398075 cites W2294478133 @default.
• W4313398075 cites W2338591330 @default.
• W4313398075 cites W2345568581 @default.
• W4313398075 cites W2403007052 @default.
• W4313398075 cites W2414564534 @default.
• W4313398075 cites W2521996233 @default.
• W4313398075 cites W2564809671 @default.
• W4313398075 cites W2570056311 @default.
• W4313398075 cites W2589502627 @default.
• W4313398075 cites W2614623561 @default.
• W4313398075 cites W2618853782 @default.
• W4313398075 cites W2739954294 @default.
• W4313398075 cites W2741828968 @default.
• W4313398075 cites W2744853370 @default.
• W4313398075 cites W2749484673 @default.
• W4313398075 cites W2755360248 @default.
• W4313398075 cites W2764120652 @default.
• W4313398075 cites W2767343890 @default.
• W4313398075 cites W2768677065 @default.
• W4313398075 cites W2770810616 @default.
• W4313398075 cites W2776991814 @default.
• W4313398075 cites W2780310856 @default.
• W4313398075 cites W2788291097 @default.
• W4313398075 cites W2791512052 @default.
• W4313398075 cites W2803022729 @default.
• W4313398075 cites W2803257972 @default.
• W4313398075 cites W2804830635 @default.
• W4313398075 cites W2812468992 @default.
• W4313398075 cites W2884605745 @default.
• W4313398075 cites W2885666326 @default.
• W4313398075 cites W2886380636 @default.
• W4313398075 cites W2889117947 @default.
• W4313398075 cites W2889688009 @default.
• W4313398075 cites W2898989437 @default.

• next